Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma

American Journal of Clinical Pathology

Volumn 105, Issue 5, 1996, Pages 538-543

  Nguyen, Phuong L ^a   Zukerberg, Lawrence R ^a   Benedict, William F ^b   Harris, Nancy L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; bcl 2; Cell cycle; Cytologic grade; Follicle center; Lymphoma; p53; Programmed cell death; Retinoblastoma protein

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CELL DEATH; CLINICAL ARTICLE; FOLLICULAR LYMPHOMA; GENE MUTATION; HISTOGENESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE;

EID: 0030007232     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.5.538     Document Type: Article

References (31)

1. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hé matologic cell lineages. Blood 1994;84:2391-2411.
2. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994;84:2412-2421.
3. Ichikawa A, Hotta T, Takagi N, et al. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 1992;49:2701-2707.
4. Wada M, Bartram CR, Nakamura H, et al. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 1993;82:3163-3169.
5. Soini Y, Paakko P, Alavaikko M, Vahakangas K. p53 expression in lymphatic malignancies. J Clin Pathol 1992;45:1011-1014.
6. Villuendas R, Piris MA, Orradre JL, et al. p53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol 1992;166: 235-241.
7. Said JW, Barrera R, Shintaku IP, Nakamura H, Koeffler HP. Immunohistochemical analysis of p53 expression in malignant lymphomas. Am J Pathol 1992;141:1343-1348.
8. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-679.
9. Cossman J, Schlegel R. p53 in the diagnosis of human neoplasia. J Natl Cancer Inst 1991;83:980-981.
10. Bartek J, Iggo R, Cannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990;5:893-899.
11. Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993;82:2289-2295.
12. Sander CA, Yano T, Clark HM, et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993;72:1994-2004.
13. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994;54:2095-2097.
14. Silvestrini R, Veneroni S, Daidone MG, et al. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 1994;86:499-504.
15. Piris MA, Pezzella F, Martinez-Montero JC, et al. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br J Cancer 1994;69:337-341.
16. Pezzella F, Morrison H, Jones M, et al. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993;22:39-44.
17. Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317:1185-9.
18. Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphoma of the bcl-1 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988;318:1638-1644.
19. Pezzella F, Tse AGD, Cordell JL, et al. Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosomal translocation. Am J Pathol 1990;137:225-232.
20. Gaulard P, d'Agay M-F, Peuchmaur M, et al. Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 1992;140: 1089-1095.
21. Benedict WF, Xu H-J, Hu S-X. Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invent 1990;85:988-993.
22. Xu H-J. Altered retinoblastoma (RB) protein expression in human malignancies. Advances in Anatomic Pathology 1995:2:213-226.
23. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994:84:1361-1392.
24. Mann RB. Berard CW. Criteria for the cytologie subclassification of follicular Iymphomas: A proposed alternative method. Hematol Oncol 1983;1:187-192.
25. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981:29;577-580.
26. Xu H-J, Hu S-X, Cagle PT, Moore GE, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 1991;51:2735-2739.
27. Cesarman E, Inghirami G, Chadburn A, Knowles DM. High levels of p53 protein expression do not correlate with p53 gene muta-tions in anaplastic large cell lymphoma. Am J Pathol 1993;143: 845-856.
28. Villuendas R, Piris MA, Algara P, et al. The expression of p53 protein in non-Hodgkin's Iymphomas is not always dependent on p53 gene mutations. Blood 1993;82:3151-3156.
29. 1 phase of the cell cycle. Cell 1991;67:293-302.
30. 1 cells: Correlation to changes in total RB protein level. Oncogene 1991;6:1139-1146.
31. Cordon-Cardo C, Richon VM. Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Palhol 1994:144:500-510.